Results 61 to 70 of about 55,779 (204)

Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Pathogens, 2020
The four serotypes of dengue virus are the most widespread causes of arboviral disease, currently placing half of the human population at risk of infection.
Lucas Wilken, Guus F. Rimmelzwaan
doaj   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

Transplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez, Carla Niveyro, Pedro Andrés Villalba Apestegui, Victoria Isabel Martin, Lucila María Compañy Kec, María Cynthia Tomasino, Mariana del Carmen del Marull, Haydee Ingrid Bernard, Claudia Patricia Lorena Fernández, Flavia Marcela Pelech, Maria Fernanda Tosin, María Fernanda González‐Hobecker, Karen Beatrice Duranona, Angela Daiana Jara, Justus Cornely, Oliver A. Cornely, Jon Salmanton‐García   +16 more
wiley   +1 more source

Knowledge, acceptance and willingness to pay for Dengue vaccine in Yogyakarta and Jakarta

Epidemiology, Biostatistics and Public Health, 2023
Despite the fact that Dengue Hemorrhagic Fever (DHF) is one of diseases with the highest incidence rate in Indonesia, its prevention strategies remain ineffective. One of the most cost-effective strategies to prevent DHF is through vaccination.
Woro Supadmi, Dyah A Perwitasari, Rizky Abdulah , Auliya Abdurrohim Suwantika   +3 more
doaj   +1 more source

Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.
ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode, Mitchel C. Rothholz, Stephan L. Foster, Erica R. Brody, John D. Gräbenstein   +4 more
wiley   +1 more source

Wolbachia versus dengue: Evolutionary forecasts. [PDF]

, 2013
A novel form of biological control is being applied to the dengue virus. The agent is the maternally transmitted bacterium Wolbachia, naturally absent from the main dengue vector, the mosquito Aedes aegypti.
Bull, James J, Turelli, Michael
core   +1 more source

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines. [PDF]

, 2018
Licensing and decisions on public health use of a vaccine rely on a robust clinical development program that permits a risk-benefit assessment of the product in the target population.
Barrett, ADT, Carrijo, K, Cavaleri, M, de Silva, A, Durbin, AP, Endy, T, Harris, E, Hombach, J, Innis, BL, Katzelnick, LC, Smith, PG, Sun, W, Thomas, SJ, Vannice, KS, Wilder-Smith, A   +14 more
core   +2 more sources

Allosteric Regulation of RNA Affinity by Motif V‐VI Coupling in West Nile Virus NS3 Helicase

Proteins: Structure, Function, and Bioinformatics, Volume 94, Issue 6, Page 1212-1224, June 2026.
ABSTRACT The rise of flaviviral diseases, including West Nile virus (WNV), presents a growing threat to global public health and underscores the urgent need for new therapeutic strategies. The non‐structural protein 3 helicase (NS3h) of the Orthoflavivirus genus, including WNV, is essential for viral replication and a promising antiviral target ...
Priti Roy, Martin McCullagh
wiley   +1 more source

Infectious Disease Ontology [PDF]

, 2009
Technological developments have resulted in tremendous increases in the volume and diversity of the data and information that must be processed in the course of biomedical and clinical research and practice.
A Bresell, A Djebbari, A Doms, A Ruttenberg, A Valouev, AC Yu, B Grinde, B Smith, B Smith, B Smith, B Smith, B Zhang, BR Zeeberg, C Medigue, C Rosse, C Schonbach, C Wolting, CA Schurink, CH Kim, D Huang, D Pisanelli, DA Natale, DL Buckeridge, DL Buckeridge, DL Rubin, DL Rubin, DP Hill, E Camon, F Baader, G Grumbling, H Tveit, HM Muller, I Spasic, J Bard, J Chabalier, J Kohler, JA Blake, JA Lee, JD Osborne, JM Cherry, K Thursky, KL Rickard, KM Coonan, LT Detwiler, M Brameier, M Coleman, M Rajapakse, MF Ochs, N Guarino, N Tiffin, NC Ide, O Bodenreider, O Bodenreider, PL Whetzel, R Cornet, SA Racunas, SE Baranzini, SL Pestotnik, TG Veenema, V Sintchenko, W Ceusters, W Ceusters, W Ceusters   +62 more
core   +3 more sources

Community Awareness, Knowledge, Attitudes, and Perceptions Toward Viral Disease Outbreaks in Dar es Salaam, Tanzania

Public Health Challenges, Volume 5, Issue 2, June 2026.
High awareness of viral outbreaks in Dar es Salaam coexists with critical knowledge gaps, stigma, and vaccine hesitancy driven by trust and safety concerns. Targeted myth correction, anti‐stigma initiatives, and strategic digital health communication are essential to strengthen community preparedness and outbreak response.
Mohammed Elmogiera Fadlallh Elsayed, Emmanuel J. Magandi, Sima Rugarabamu   +2 more
wiley   +1 more source

Risk of Dengue in Travelers: Implications for Dengue Vaccination [PDF]

Current Infectious Disease Reports, 2018
Dengue is found in tropics and subtropics that are considered to be popular travel destinations. We set out to review the burden of dengue on international travelers.GeoSentinel, a global network of travel medicine providers, has seen an increasing trend of dengue in returning travelers over the past decades.
openaire   +2 more sources